Evidence map›Paper›PMID 37297835›Full record

ArticleJournal of clinical medicine2023

Prediction of Cervical Lymph Node Metastasis in Clinically Node-Negative T1 and T2 Papillary Thyroid Carcinoma Using Supervised Machine Learning Approach.

Marina Popović Krneta, Dragana Šobić Šaranović, Ljiljana Mijatović Teodorović, Nemanja Krajčinović, Nataša Avramović, Živko Bojović, Zoran Bukumirić, Ivan Marković, Saša Rajšić, Biljana Bazić Djorović and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Marina Popović KrnetaDepartment of Nuclear Medicine, Institute for Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.ORCID 0000-0002-7627-453X
Dragana Šobić ŠaranovićFaculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.ORCID 0000-0001-9600-090X
Ljiljana Mijatović TeodorovićDepartment of Nuclear Medicine, Institute for Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.
Nemanja KrajčinovićDepartment of Power, Electronics and Telecommunications, Faculty of Technical Sciences, University of Novi Sad, 21 000 Novi Sad, Serbia.ORCID 0009-0005-5218-4037
Nataša AvramovićDepartment of Power, Electronics and Telecommunications, Faculty of Technical Sciences, University of Novi Sad, 21 000 Novi Sad, Serbia.
Živko BojovićDepartment of Power, Electronics and Telecommunications, Faculty of Technical Sciences, University of Novi Sad, 21 000 Novi Sad, Serbia.
Zoran BukumirićInstitute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.
Ivan MarkovićFaculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.
Saša RajšićDepartment of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6193-3662
Biljana Bazić DjorovićDepartment of Nuclear Medicine, Institute for Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.
Vera ArtikoFaculty of Medicine, University of Belgrade, 11 000 Belgrade, Serbia.
Mihajlo KarličićSchool of Electrical Engineering, University of Belgrade, 11 000 Belgrade, Serbia.
Miljana TanićDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, 11 000 Belgrade, Serbia.ORCID 0000-0003-3102-776X
University of Belgrade · RSOncology Institute of Vojvodina · RSUniversity of Novi Sad · RSInnsbruck Medical University · ATUniversity of Kragujevac · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary thyroid carcinoma (PTC) is generally considered an indolent cancer. However, patients with cervical lymph node metastasis (LNM) have a higher risk of local recurrence. This study evaluated and compared four machine learning (ML)-based classifiers to predict the presence of cervical LNM in clinically node-negative (cN0) T1 and T2 PTC patients. The algorithm was developed using clinicopathological data from 288 patients who underwent total thyroidectomy and prophylactic central neck dissection, with sentinel lymph node biopsy performed to identify lateral LNM. The final ML classifier was selected based on the highest specificity and the lowest degree of overfitting while maintaining a sensitivity of 95%. Among the models evaluated, the k-Nearest Neighbor (k-NN) classifier was found to be the best fit, with an area under the receiver operating characteristic curve of 0.72, and sensitivity, specificity, positive and negative predictive values, F1 and F2 scores of 98%, 27%, 56%, 93%, 72%, and 85%, respectively. A web application based on a sensitivity-optimized kNN classifier was also created to predict the potential of cervical LNM, allowing users to explore and potentially build upon the model. These findings suggest that ML can improve the prediction of LNM in cN0 T1 and T2 PTC patients, thereby aiding in individual treatment planning.

Indexed as

lymph node metastasismachine learningpapillary thyroid carcinoma

Identifiers

PMID37297835
PMCPMC10253788
OpenAlexW4378228185

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.